JAK-STAT pathway inhibitors in dermatology-Reference-Cited by-同舟云学术

JAK-STAT pathway inhibitors in dermatology

Published:2023-09 Issue:5 Volume:98 Page:656-677
ISSN:0365-0596
Container-title:Anais Brasileiros de Dermatologia
language:en
Short-container-title:Anais Brasileiros de Dermatologia

Author:

Miot Hélio Amante^ORCID,Criado Paulo Ricardo^ORCID,de Castro Caio César Silva^ORCID,Ianhez Mayra^ORCID,Talhari Carolina^ORCID,Ramos Paulo Müller^ORCID

Publisher

Elsevier BV

Subject

Dermatology

Reference137 articles.

1. Janus kinase inhibitors in dermatology: part I. A comprehensive review;Chapman;J Am Acad Dermatol,2022

2. The STATs in cell stress-type responses;Dudley;Cell Commun Signal,2004

3. Janus kinase inhibitors in dermatology: part II. A comprehensive review;Chapman;J Am Acad Dermatol,2022

4. Canonical and non-canonical JAK-STAT signaling;Li;Trends Cell Biol,2008

5. Basic Mechanisms of JAK Inhibition;Lin;Mediterr J Rheumatol,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prurigo: review of its pathogenesis, diagnosis, and treatment;Anais Brasileiros de Dermatologia;2024-09

2. Biomarker Landscape in RASopathies;International Journal of Molecular Sciences;2024-08-06

3. 578 - Cost per responder in Brazil (EASI-75, EASI90 and ΔNRS ≥4) of biologics and JAK inhibitors based on a network-meta-analysis of therapies for atopic dermatitis;British Journal of Dermatology;2024-08

4. Efficacy and Safety of JAK-STAT Inhibitors in the Treatment of Moderate to Severe Plaque Psoriasis: a Meta Analysis;Journal of Contemporary Medical Practice;2024-07-28

5. Sarcoidosis and Polymethyl Methacrylate (PMMA) Granulomas following COVID-19 Vaccination (ChAdOx1): Successful Treatment with Tofacitinib;Indian Journal of Dermatology;2024-07